BlackRock’s Kestra Medical Technologies KMTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.5M Buy
1,865,496
+176,249
+10% +$3.69M ﹤0.01% 2707
2026
Q1
$33.7M Buy
1,689,247
+454,561
+37% +$10.7M ﹤0.01% 2761
2025
Q4
$32.7M Buy
1,234,686
+377,041
+44% +$9.71M ﹤0.01% 2791
2025
Q3
$20.4M Buy
857,645
+58,875
+7% +$1.05M ﹤0.01% 3082
2025
Q2
$13.2M Buy
798,770
+798,340
+185,660% +$17.4M ﹤0.01% 3260
2025
Q1
$10.7K Buy
+430
New +$9.88K ﹤0.01% 5172

Other funds holding KMTS

BlackRock's KMTS Position: Q2 2026 in Review

BlackRock increased its Kestra Medical Technologies (KMTS) stake by 10% in Q2 2026, buying an estimated $3.69M and bringing the position to 1,865,496 shares worth $47.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2707.

BlackRock first reported a position in KMTS in Q1 2025 and has held it in 6 quarters since. 108 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • BlackRock held 1,865,496 shares of Kestra Medical Technologies worth $47.5M as of Q2 2026.
  • BlackRock bought 176,249 Kestra Medical Technologies shares in Q2 2026, an estimated $3.69M.
  • Kestra Medical Technologies made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2707 holding.
  • BlackRock first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 6 quarters since.
  • 108 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.